Thermo Fisher Scientific & Telangana government partner to set-up bioprocess design centre to advance novel biotherapeutics in India
Thermo Fisher Scientific has inked a Memorandum of Understanding (MoU) with the Government of Telangana to establish a bioprocess design centre (BDC) in Genome Valley, Hyderabad.
Telangana minister for IT&E, industries & commerce and legislative affairs, Duddilla Sridhar Babu, said, “The establishment of this bioprocess design centre reflects the state’s progressive policies and collaborative approach to building a robust biopharma infrastructure.
With over 1,800 companies, Telangana is leading the way in making India a global hub for biopharma innovation. We partner with Thermo Fisher, the world leader in serving science, which is a transformative initiative that will advance the future of healthcare.”
Shakthi Nagappan, director of lifesciences and pharma, Government of Telangana, stated, “This partnership with Thermo Fisher marks a significant milestone in our efforts to build a first-of-its-kind bioprocessing facility for biologics manufacturing in India.
The centre, featuring single-use bioreactors, will enhance the biopharma sector by offering pay-per-use infrastructure, technical expertise, and cutting-edge research solutions, helping companies reduce their time to market. It will not only drive the growth of biopharma manufacturing in Telangana but also bolster India's position on the global map."
Thermo Fisher will equip the centre with advanced workflow capabilities across upstream and downstream research, cell culture media development, single-use scale-up manufacturing, and product validation.
Daniella Cramp, sr. vice president & president, bioproduction, Thermo Fisher Scientific said, “I sincerely thank the Government of Telangana for partnering with Thermo Fisher and supporting our mission. This state-of-the-art facility will enable academic researchers, biopharma start-ups and companies to fast-track their innovations by meeting their end-to-research and manufacturing needs.”
Tony Acciarito, president, APJ, Thermo Fisher Scientific, further added, ""The signing of this MoU marks an exciting new chapter for Thermo Fisher in India, reaffirming our continued commitment to fostering scientific innovation in the country. Our partnership with the Government of Telangana will strengthen India's biopharma manufacturing capabilities, accelerating the development of breakthrough therapeutics and advancing healthcare solutions that will benefit patients globally."
Srinath Venkatesh, managing director, India & South Asia, Thermo Fisher Scientific, said, “India is fast emerging as a global biopharma hub, with significant growth in research and development driven by key pharmaceutical and biotech companies. The bioprocess design centre underscores our commitment to empowering our customers through technological advancements. By focusing on areas like oncology, cell and gene therapies, and biotherapeutics, we aim to drive breakthroughs for a healthier world.”
Hyderabad is recognized as the new destination for large biotech and life sciences companies due to enabling government policies and industrial practices, infrastructure facilities and a diverse talent ecosystem of skilled professionals in chemistry, biology, genetics, technology and beyond.
Thermo Fisher has already established a state-of-the-art R&D and engineering centre in Hyderabad to support product designing, development, reliability performance testing and verification, as well as validation of products.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!